Case Report

Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case

Volume: 13 Number: 1 April 26, 2023
  • Mustafa Özay

Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case

Abstract

Hyperleukocytosis is defined as a blood blast count >100.000/ mm3 and may occur most commonly in monocytic (M4) acute myeloid leukemia (AML). Hyperleukocytosis is a medical emergency associated with lung and central nervous system leukostasis. An 18-month-old female patient was brought to our clinic with anemia, thrombocytopenia, and leukocytosis with bilateral palpebral swelling/proptosis, a palpable mass in the midline, and lymphadenopathy in the neck. Myeloid sarcoma was suspected. The patient had AML M4 morphological features, and 47,XX + mar was detected in bone marrow karyotype analysis. She had complications such as hyperleukocytosis, leukostasis (blurring of consciousness, tachypnea/tachycardia), tumor lysis syndrome, and disseminated intravascular coagulation. In addition to low-dose cytoreduction chemotherapy, leukocyte apheresis was performed. All symptoms and complaints of the patient disappeared. Therefore, myeloid sarcoma should be considered in young children with orbital swelling/ proptosis, an abdominal mass, high leukocyte count at diagnosis, AML M4 morphological features, and diffuse intravascular coagulation.

Keywords

References

  1. 1. Emadi A, Baer MR. Acute myeloid leukemia in adults. In: Greer JP, Arber DA, Glader B, List AF, Means Jr RT, Paraskevas F, Rodges GM. Wintrobe’s Clinical Hematology, 13th ed. Philadelphia: Lippincott Williams & Wilkins. 2014: 35913695.
  2. 2. Creutzig U, Ritter J, Budde M, Sutor A, Schellong G. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia. Cancer. 1987; 60:3071.
  3. 3. Beckmann L, Rolling CC, Voigtländer M, Mäder J, Klingler F, Schulenkorf A et al. Bacitracin and rutin regulate tissue factor production in inflammatory monocytes and acute myeloid leukemia blasts. Cancers (Basel). 2021 Aug 4; 13(16):3941
  4. 4. Dicke C, Amirkhosravi A, Spath B, Jiménez-Alcázar M, Fuchs T, Davila M et al. Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study. Exp Hematol Oncol. 2015 Aug 6; 4:22.
  5. 5. Bruserud Ø, Liseth K, Stamnesfet S, Cacic DL, Melve G, Kristoffersen E et al. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia. Transfus Med. 2013 Dec; 23(6):397-406.
  6. 6. Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012; 26:117.
  7. 7. Oberoi S, Lehrnbecher T, Phillips B, Hitzler J, Ethier MC, Beyene J et al. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis. Leuk Res. 2014 Apr; 38(4):460-8.
  8. 8. Dusenbery KE, Howells WB, Arthur DC, Alonzo T, Lee JW, Kobrinsky N et al. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children’s Cancer Group. J Pediatr Hematol Oncol. 2003; 25:760.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Case Report

Authors

Mustafa Özay This is me
Türkiye

Publication Date

April 26, 2023

Submission Date

December 7, 2022

Acceptance Date

December 28, 2022

Published in Issue

Year 2023 Volume: 13 Number: 1

APA
Özay, M. (2023). Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case. Kafkas Journal of Medical Sciences, 13(1), 87-90. https://izlik.org/JA46PD49SW
AMA
1.Özay M. Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case. Kafkas Journal of Medical Sciences. 2023;13(1):87-90. https://izlik.org/JA46PD49SW
Chicago
Özay, Mustafa. 2023. “Acute Myeloid Leukemia (M4) Myeloid Sarcoma Presenting With Hyperleukocytosis, 47,XX + Mar Case”. Kafkas Journal of Medical Sciences 13 (1): 87-90. https://izlik.org/JA46PD49SW.
EndNote
Özay M (April 1, 2023) Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case. Kafkas Journal of Medical Sciences 13 1 87–90.
IEEE
[1]M. Özay, “Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case”, Kafkas Journal of Medical Sciences, vol. 13, no. 1, pp. 87–90, Apr. 2023, [Online]. Available: https://izlik.org/JA46PD49SW
ISNAD
Özay, Mustafa. “Acute Myeloid Leukemia (M4) Myeloid Sarcoma Presenting With Hyperleukocytosis, 47,XX + Mar Case”. Kafkas Journal of Medical Sciences 13/1 (April 1, 2023): 87-90. https://izlik.org/JA46PD49SW.
JAMA
1.Özay M. Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case. Kafkas Journal of Medical Sciences. 2023;13:87–90.
MLA
Özay, Mustafa. “Acute Myeloid Leukemia (M4) Myeloid Sarcoma Presenting With Hyperleukocytosis, 47,XX + Mar Case”. Kafkas Journal of Medical Sciences, vol. 13, no. 1, Apr. 2023, pp. 87-90, https://izlik.org/JA46PD49SW.
Vancouver
1.Mustafa Özay. Acute Myeloid Leukemia (M4)/Myeloid Sarcoma Presenting with Hyperleukocytosis, 47,XX + mar Case. Kafkas Journal of Medical Sciences [Internet]. 2023 Apr. 1;13(1):87-90. Available from: https://izlik.org/JA46PD49SW